» Articles » PMID: 19366800

Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Apr 16
PMID 19366800
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma multiforme (GBM) are aggressive and uniformly fatal primary brain tumors characterized by their diffuse invasion of the normal-appearing parenchyma peripheral to the clinical imaging abnormality. Hypoxia, a hallmark of aggressive tumor behavior often noted in GBMs, has been associated with resistance to therapy, poorer survival, and more malignant tumor phenotypes. Based on the existence of a set of novel imaging techniques and modeling tools, our objective was to assess a hypothesized quantitative link between tumor growth kinetics [assessed via mathematical models and routine magnetic resonance imaging (MRI)] and the hypoxic burden of the tumor [assessed via positron emission tomography (PET) imaging]. Our biomathematical model for glioma kinetics describes the spatial and temporal evolution of a glioma in terms of concentration of malignant tumor cells. This model has already been proven useful as a novel tool to dynamically quantify the net rates of proliferation (rho) and invasion (D) of the glioma cells in individual patients. Estimates of these kinetic rates can be calculated from routinely available pretreatment MRI in vivo. Eleven adults with GBM were imaged preoperatively with (18)F-fluoromisonidazole (FMISO)-PET and serial gadolinium-enhanced T1- and T2-weighted MRIs to allow the estimation of patient-specific net rates of proliferation (rho) and invasion (D). Hypoxic volumes were quantified from each FMISO-PET scan following standard techniques. To control for tumor size variability, two measures of hypoxic burden were considered: relative hypoxia (RH), defined as the ratio of the hypoxic volume to the T2-defined tumor volume, and the mean intensity on FMISO-PET scaled to the blood activity of the tracer (mean T/B). Pearson correlations between RH and the net rate of cell proliferation (rho) reached significance (P < 0.04). Moreover, highly significant positive correlations were found between biological aggressiveness ratio (rho/D) and both RH (P < 0.00003) and the mean T/B (P < 0.0007).

Citing Articles

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET.

Wang Y, Fushimi Y, Arakawa Y, Shimizu Y, Sano K, Sakata A Jpn J Radiol. 2023; 41(11):1255-1264.

PMID: 37219717 PMC: 10613590. DOI: 10.1007/s11604-023-01450-x.


Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, F-FMISO PET, and F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma.

Collet S, Guillamo J, Berro D, Chakhoyan A, Constans J, Lechapt-Zalcman E J Nucl Med. 2021; 62(10):1349-1356.

PMID: 34016725 PMC: 8724903. DOI: 10.2967/jnumed.120.249524.


Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer.

Yoon J, Kang S, Lee K, Cheon G, Oh D Cancer Res Treat. 2020; 53(2):471-479.

PMID: 33091966 PMC: 8053876. DOI: 10.4143/crt.2020.577.


Imaging of intratumoral heterogeneity in high-grade glioma.

Hu L, Hawkins-Daarud A, Wang L, Li J, Swanson K Cancer Lett. 2020; 477:97-106.

PMID: 32112907 PMC: 7108976. DOI: 10.1016/j.canlet.2020.02.025.


Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI.

Gaw N, Hawkins-Daarud A, Hu L, Yoon H, Wang L, Xu Y Sci Rep. 2019; 9(1):10063.

PMID: 31296889 PMC: 6624304. DOI: 10.1038/s41598-019-46296-4.


References
1.
Swanson K, Alvord Jr E, Murray J . A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif. 2000; 33(5):317-29. PMC: 6621920. DOI: 10.1046/j.1365-2184.2000.00177.x. View

2.
Rajendran J, Mankoff D, OSullivan F, Peterson L, Schwartz D, Conrad E . Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004; 10(7):2245-52. DOI: 10.1158/1078-0432.ccr-0688-3. View

3.
Swanson K, Alvord Jr E, Murray J . Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer. 2002; 86(1):14-8. PMC: 2746525. DOI: 10.1038/sj.bjc.6600021. View

4.
Fyles A, Milosevic M, Wong R, Kavanagh M, Pintilie M, Sun A . Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 1998; 48(2):149-56. DOI: 10.1016/s0167-8140(98)00044-9. View

5.
Cher L, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A . Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med. 2006; 47(3):410-8. View